NEW YORK (Reuters Health) – In diabetic patients, sirolimus-eluting stents reduce the risk for coronary artery restenosis compared with paclitaxel-eluting stents, a meta-analysis shows. Because the relative efficacy…
NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with…
NEW YORK (Reuters Health) – New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality. According to a report in the…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses diabesity, obesity with diabetes, and reminds doctors why we need to screen patients first for…
NEW YORK (Reuters Health) – The ratio of triglycerides to HDL cholesterol (TG/HDL) predicts first coronary events in men regardless of body-mass index, say researchers in the November…
Dr Mark Del Beccaro, MD, Pediatrician in Chief, Chief Medical Information Officer and Vice Chair of Clinical Affairs for the Department of Pediatrics at Seattle Children’s Hospital, Professor…
NEW YORK (Reuters Health) – Systolic blood pressure, left ventricular (LV) mass, and diabetes status independently predict the likelihood that prehypertensive patients with cardiac risk factors will develop…
NEW YORK (Reuters Health) – An “important” relation exists between platelet reactivity and glycemic control in patients with type 2 diabetes and coronary artery disease who are on…
NEW YORK (Reuters Health) – Brown adipose tissue (BAT) is much more active in humans during the winter than in the summer, according to a report in the…